Swedish Orphan Biovitrum AB (FRA:B6E) Cyclically Adjusted Book per Share: €6.70 (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:B6E Swedish Orphan Biovitrum AB FRA:B6E
86 GF Score
Price €41.44
GF Value €30.99
Valuation Significantly Overvalued
! 6 Warning Signs
View Full Analysis

What is Swedish Orphan Biovitrum AB Cyclically Adjusted Book per Share?

Swedish Orphan Biovitrum AB FRA:B6E -1.80% 86 Cyclically Adjusted Book per Share is €6.70 as of Mar. 2026. GuruFocus rates FRA:B6E with a GF Score™ of 86/100 and a GF Value™ of €30.99 (Significantly Overvalued). The stock has 6 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

Swedish Orphan Biovitrum AB's adjusted book value per share for the three months ended in Mar. 2026 was €10.839. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €6.70 for the trailing ten years ended in Mar. 2026.

During the past 12 months, Swedish Orphan Biovitrum AB's average Cyclically Adjusted Book Growth Rate was 14.10% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 17.50% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 21.40% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of Swedish Orphan Biovitrum AB was 24.50% per year. The lowest was 13.00% per year. And the median was 19.55% per year.

As of today (2026-07-15), Swedish Orphan Biovitrum AB's current stock price is €41.44. Swedish Orphan Biovitrum AB's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2026 was €6.70. Swedish Orphan Biovitrum AB's Cyclically Adjusted PB Ratio of today is 6.19.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Swedish Orphan Biovitrum AB was 13.83. The lowest was 3.88. And the median was 5.58.


Swedish Orphan Biovitrum AB  (FRA:B6E) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Swedish Orphan Biovitrum AB's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=41.44/6.70
=6.19

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted PB Ratio of Swedish Orphan Biovitrum AB was 13.83. The lowest was 3.88. And the median was 5.58.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


Swedish Orphan Biovitrum AB Cyclically Adjusted Book per Share Related Terms


Swedish Orphan Biovitrum AB Cyclically Adjusted Book per Share Historical Data

* Premium members only.

The historical data trend for Swedish Orphan Biovitrum AB's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Swedish Orphan Biovitrum AB Cyclically Adjusted Book per Share Chart

Swedish Orphan Biovitrum AB Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.26 3.96 4.88 5.51 6.67

Swedish Orphan Biovitrum AB Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 5.95 6.12 6.31 6.67 6.70

FRA:B6E vs ZTS, UTHR: Cyclically Adjusted Book per Share Comparison

For the Drug Manufacturers - Specialty & Generic subindustry, Swedish Orphan Biovitrum AB's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Swedish Orphan Biovitrum AB Cyclically Adjusted PB Ratio vs Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Swedish Orphan Biovitrum AB's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Swedish Orphan Biovitrum AB's Cyclically Adjusted PB Ratio falls into.


FRA:B6E
86GF Score
Swedish Orphan Biovitrum AB FRA:B6E
Cyclically Adjusted Book per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Swedish Orphan Biovitrum AB Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Swedish Orphan Biovitrum AB's adjusted Book Value per Share data for the three months ended in Mar. 2026 was:

Adj_Book= Book Value per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=10.839/133.5600*133.5600
=10.839

Current CPI (Mar. 2026) = 133.5600.

Swedish Orphan Biovitrum AB Quarterly Data

Book Value per Share CPI Adj_Book
201606 1.999 101.019 2.643
201609 1.993 101.138 2.632
201612 1.963 102.022 2.570
201703 2.084 102.022 2.728
201706 2.172 102.752 2.823
201709 2.362 103.279 3.055
201712 2.393 103.793 3.079
201803 2.519 103.962 3.236
201806 2.709 104.875 3.450
201809 2.884 105.679 3.645
201812 3.114 105.912 3.927
201903 4.479 105.886 5.650
201906 4.574 106.742 5.723
201909 4.765 107.214 5.936
201912 5.243 107.766 6.498
202003 5.566 106.563 6.976
202006 5.753 107.498 7.148
202009 5.833 107.635 7.238
202012 6.433 108.296 7.934
202103 6.645 108.360 8.190
202106 6.774 108.928 8.306
202109 6.919 110.338 8.375
202112 7.311 112.486 8.681
202203 7.298 114.825 8.489
202206 7.405 118.384 8.354
202209 7.488 122.296 8.178
202212 7.785 126.365 8.228
202303 7.989 127.042 8.399
202306 7.823 129.407 8.074
202309 8.575 130.224 8.795
202312 8.911 131.912 9.022
202403 9.331 132.205 9.427
202406 9.397 132.716 9.457
202409 9.514 132.304 9.604
202412 10.198 132.987 10.242
202503 10.374 132.825 10.431
202506 10.292 133.699 10.281
202509 9.489 133.480 9.495
202512 10.027 133.390 10.040
202603 10.839 133.560 10.839

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

What does a Cyclically Adjusted Book per Share of €6.70 mean?
Swedish Orphan Biovitrum AB (FRA:B6E) has a Cyclically Adjusted Book per Share of €6.70 as of Mar. 2026. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Swedish Orphan Biovitrum AB and its competitors.
Is Swedish Orphan Biovitrum AB's Cyclically Adjusted Book per Share too high?
Swedish Orphan Biovitrum AB's current Cyclically Adjusted Book per Share is €6.70. Overall, Swedish Orphan Biovitrum AB has a GF Score™ of 86/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Swedish Orphan Biovitrum AB's Cyclically Adjusted Book per Share compare to ZTS and UTHR?
Swedish Orphan Biovitrum AB's Cyclically Adjusted Book per Share of €6.70 can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted Book per Share for a Drug Manufacturers company?
A good Cyclically Adjusted Book per Share depends on the Drug Manufacturers industry context. However, Cyclically Adjusted Book per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted Book per Share mean?
A high Cyclically Adjusted Book per Share can signal that a stock is expensive relative to its fundamentals. Cyclically adjusted book value per share represents the company's inflation-adjusted book value per share over a 10-year period. View historical data on Swedish Orphan Biovitrum AB and its competitors. Swedish Orphan Biovitrum AB's current Cyclically Adjusted Book per Share is €6.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Swedish Orphan Biovitrum AB stock overvalued right now?
Based on GuruFocus' analysis, Swedish Orphan Biovitrum AB (FRA:B6E) is currently considered Significantly Overvalued. The stock's GF Value™ is €30.99, compared to a current price of €41.44 — trading 33.7% above its estimated fair value. The current Cyclically Adjusted Book per Share is €6.70. Swedish Orphan Biovitrum AB's overall GF Score™ is 86/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted Book per Share calculated?
Cyclically Adjusted Book per Share is calculated from a company's financial statements. For Swedish Orphan Biovitrum AB (FRA:B6E), the current Cyclically Adjusted Book per Share is €6.70 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Swedish Orphan Biovitrum AB (FRA:B6E) Overvalued in 2026?

Based on GuruFocus' analysis, Swedish Orphan Biovitrum AB stock appears to be overvalued. The current stock price of €41.44 is trading 33.7% above its estimated GF Value™ of €30.99. GuruFocus considers Swedish Orphan Biovitrum AB to be Significantly Overvalued.

Key valuation signals for FRA:B6E:

  • Cyclically Adjusted Book per Share: €6.70
  • GF Value™: €30.99 vs. price of €41.44 (33.7% above fair value)
  • GF Score™: 86/100 with 6 warning signs

No single metric tells the full story. See the FRA:B6E stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Swedish Orphan Biovitrum AB Business Description

Address Norra Stationsgatan 93A, Stockholm, SWE, SE-112 76
Swedish Orphan Biovitrum, or Sobi, focuses on rare diseases, primarily in hematology and immunology. Biovitrum started with experience in studying recombinant proteins such as hemophilia factors, and partnered with Syntonix (now part of Sanofi) in 2006 on long-acting hemophilia factor replacement programs. Biovitrum acquired Orfadin and a partnered product business with the acquisition of Swedish Orphan. Sobi launched hemophilia products Alprolix and Eloctate in Europe in 2016, and Altuvoct in 2024. Sobi has been building its immunology pipeline (rare-disease drug Gamifant, US rights to RSV antibodies Synagis and Beyfortus, gout drugs, complement drug Aspaveli) and a broader hematology pipeline (thrombocytopenia drug Doptelet, blood cancer drug Zynlonta, myelofibrosis drug Vonjo).
86GF Score

Get the complete analysis for FRA:B6E

Cyclically Adjusted Book per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€41.44
Price
€30.99
GF Value